Communicable Diseases Intelligence 2020 - Volume 44 - Home Page

Page last updated: 20 March 2020

Subscribe to CDI Newsletter

Policy and guidelines

Revised guidelines for Australian laboratories performing mycobacteriology testing

Ivan Bastian, Lisa Shephard, Richard Lumb, and the National Tuberculosis Advisory Committee || https://doi.org/10.33321/cdi.2020.44.2 || Published online: 15/1/2020
Full Text: (Word 108 KB) (PDF 2.98 MB)

Notice to readers

Antimicrobial resistance and antibiotic use in Timor-Leste: building surveillance capacity with a One Health approach

Joshua R Francis, Nevio Sarmento, Anthony D K Draper, Ian Marr, Shawn Ting, Nicholas Fancourt, Lucsendar Alves, Karen Champlin, Alexander Bongers and Jennifer Yan || https://doi.org/10.33321/cdi.2020.44.1 || Published online: 15/1/2020
Full Text: (Word 842 KB) (PDF 3.21 MB)

Original articles

Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000–2017

Julia E Maguire, Frank Beard, Kelley Méder, Aditi Dey, Kristine Macartney, Peter McIntyre || https://doi.org/10.33321/cdi.2020.44.11 || Published online: 17/2/2020
Full Text: (Word 1.65 MB) (PDF 3.09 MB)

Reports

Short report

Acute flaccid myelitis – has it gone unrecognised in Australian children?

Junchao Bao, Bruce Thorley, Elizabeth J Elliott, Peter McIntyre and Philip N Britton || https://doi.org/10.33321/cdi.2020.44.22 || Published online: 16/3/2020
Full Text: (Word 202.67 KB) (PDF 2.94 MB)

Quarterly reports

Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2019

Monica M Lahra and Rodney Enriquez for the National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.9 || Published online: 17/2/2020
Full Text: (Word 66.3 KB) (PDF 2.89 MB)

Australian Gonococcal Surveillance Programme 1 April to 30 June 2018

Monica M Lahra, Rodney P Enriquez and CR Robert George for The National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.5 || Published online: 17/2/2020
Full Text: (Word 73.3 KB) (PDF 2.82 MB)

Australian Gonococcal Surveillance Programme, 1 January to 31 March 2019

Monica M Lahra and Rodney P Enriquez for The National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.3 || Published online: 17/2/2020
Full Text: (Word 70.2 KB) (PDF 2.76 MB)

Australian Gonococcal Surveillance Programme 1 January to 31 March 2017

Monica M Lahra and Rodney P Enriquez for the National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.8 || Published online: 15/1/2020
Full Text: (Word 69.3 KB) (PDF 2.76 MB)

Australian Gonococcal Surveillance Programme 1 April to 30 June 2017

Monica M Lahra and Rodney P Enriquez for the National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.7 || Published online: 15/1/2020
Full Text: (Word 69.6 KB) (PDF 2.76 MB)

Australian Gonococcal Surveillance Programme 1 July to 30 September 2017

Monica M Lahra and Rodney P Enriquez on behalf of The National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.6 || Published online: 15/1/2020
Full Text: (Word 69.4 KB) (PDF 2.76 MB)

Annual reports

Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018

Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, Yung Thin Lee and Stanley Pang, on behalf of the Australian Group on Antimicrobial Resistance || https://doi.org/10.33321/cdi.2020.44.18 || Published online: 16/3/2020
Full Text: (Word 95.37 KB) (PDF 2.89 MB)

Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2018

Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, Yung Thin Lee and Stanley Pang, on behalf of the Australian Group on Antimicrobial Resistance || https://doi.org/10.33321/cdi.2020.44.19 || Published online: 16/3/2020
Full Text: (Word 85.32 KB) (PDF 2.86 MB)

Surveillance of adverse events following immunisation in Australia: annual report, 2018

Aditi Dey, Han Wang, Helen Quinn, Alexis Pillsbury, Catherine Glover, Megan Hickie, Nicholas Wood, Frank Beard and Kristine Macartney || https://doi.org/10.33321/cdi.2020.44.12 || Published online: 16/3/2020
Full Text: (Word 972.5 KB) (PDF 3.14 MB)

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018

Olivia H Price, Natalie Spirason, Cleve Rynehart, Sook Kwan Brown, Angela Todd, Heidi Peck, Manisha Patel, Sally Soppe, Ian G Barr and Michelle K Chow || https://doi.org/10.33321/cdi.2020.44.16 || Published online: 16/3/2020
Full Text: (Word 772.01 KB) (PDF 3.49 MB)

Australian Meningococcal Surveillance Programme annual report, 2018

Monica M Lahra, Rodney Enriquez and Tiffany Hogan for the National Neisseria Network || https://doi.org/10.33321/cdi.2020.44.10 || Published online: 16/3/2020
Full Text: (Word 1.09 MB) (PDF 3.02 MB)

Australian Gonococcal Surveillance Programme Annual Report, 2018

Monica M Lahra, Rodney Enriquez and CR Robert George for the National Neisseria Network, Australia || https://doi.org/10.33321/cdi.2020.44.4 || Published online: 17/2/2020
Full Text: (Word 200 KB) (PDF 3.13 MB)

Editorial team

The editorial team consists of the editor, deputy editor, and a designer. The editorial team is supported by an Editorial Advisory Board (EAB).

Editors:
Tanja Farmer
Cindy Toms
Deputy Editor:
Simon Petrie
Design and Production: Kasra Yousefi

Editorial advisory board

The role of the CDI Editorial Advisory Board (EAB) is to:

  • provide expert advice to the CDI editorial team; advocate for CDI in the broader community;
  • serve as a critical sounding board for the editorial team on editorial ideas and themes;
  • provide ideas for features and news and thoughts on current trends; and provide constructive feedback on published issues.
David Durrheim
Mark Ferson
John Kaldor
Martyn Kirk
Linda Selvey

Correspondence

Correspondence should be sent to: cdi.editor@health.gov.au


ISSN

ISSN: 2209-6051 (Online)


Disclaimer

Opinions expressed in Communicable Diseases Intelligence are those of the authors and not necessarily those of the Australian Government Department of Health or the Communicable Diseases Network Australia. Data may be subject to revision.